H.R. 1734 - 118th Congress (2023-2024) - TRANQ Research Act of 2023

Sponsor

Introduced

Mar 23, 2023

Latest Action

Jun 26, 2023

Origin Chamber

House

Type

Bill Number

1734

Congress

118

Policy Area

House Votes (1)

Senate Votes (1)

Passed on May 11, 2023

Question

On Motion to Suspend the Rules and Pass, as Amended

Status

Passed

Type

Roll Call Type

2/3 Yea-And-Nay

Roll Number

212

House Roll Call Votes

Republicans

Democrats

Select State

Summary

Testing, Rapid Analysis, and Narcotic Quality Research Act or the TRANQ Research Act

This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other emerging substances of concern.

In particular, NIST must support

basic measurement science and research, including graduate and postgraduate research;
near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance);
strategies and voluntary best practices for handling, transporting, and analyzing such substances; and
collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities.

Text (5)

Engrossed Amendment Senate

June 22, 2023

May 15, 2023

May 11, 2023

May 5, 2023

March 23, 2023

Amendments (1)

Jun 22, 2023

Agreed to in Senate

Sponsorship

Senate Amendment 139

in the nature of a substitute.

Agreed To

Actions (19)

Show Only Major Actions

06/26/2023

Message on Senate action sent to the House.

06/22/2023

Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S2250-2251)

06/22/2023

Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S2250-2251)

06/22/2023

Measure laid before Senate by unanimous consent. (consideration: CR S2250)

05/15/2023

Received in the Senate, read twice.

05/11/2023

Motion to reconsider laid on the table Agreed to without objection.

05/11/2023

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 425 - 0 (Roll no. 212). (text: 5/9/2023 CR H2149)

05/11/2023

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 425 - 0 (Roll no. 212).(text: 5/9/2023 CR H2149)

05/11/2023

Considered as unfinished business. (consideration: CR H2295-2296)

05/09/2023

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

05/09/2023

DEBATE - The House proceeded with forty minutes of debate on H.R. 1734.

05/09/2023

Considered under suspension of the rules. (consideration: CR H2149-2151)

05/09/2023

Mr. Miller (OH) moved to suspend the rules and pass the bill, as amended.

05/05/2023

Placed on the Union Calendar, Calendar No. 34.

05/05/2023

Reported (Amended) by the Committee on Science, Space, and Technology. H. Rept. 118-50.

03/29/2023

Ordered to be Reported (Amended) by the Yeas and Nays: 36 - 0.

03/29/2023

Committee Consideration and Mark-up Session Held.

03/23/2023

Referred to the House Committee on Science, Space, and Technology.

03/23/2023

Introduced in House